Innatoss Innovative diagnostics Expert in intracellular infectious - PowerPoint PPT Presentation

Aug 16, 2022 •236 likes •378 views

Innatoss Innovative diagnostics Expert in intracellular infectious diseases Diagnostics for Lyme disease 2 Expert in intracellular infectious diseases and Q fever 3 For the complete story in immunity Humoral immunity Cellular

Innatoss Innovative diagnostics
Expert in intracellular infectious diseases Diagnostics for Lyme disease … 2
Expert in intracellular infectious diseases … and Q fever 3
For the complete story in immunity Humoral immunity Cellular immunity + B-cells T-cells T-cel activity Serology Interferon- ɣ IgG - IgM 4
Reference lab for cellular testing Independent and specialized Centralized knowledge on infectious disease diagnostics Access to state of the art equipment 5
Manufacturer of cellular tests Fit to purpose and workflow High sensitivity and specificity Implemented with hands-on training 6
Dynamic organization Young, authentic , research intensive organisation Entrepreneurial culture aimed at growth, accuracy and excellence Hands-on and energetic innovation climate 7
Past – Present – Future • 2011: Foundation by Anja Garritsen • 2012: In-licensing of patent on cellular Q fever test • 2013: Development & miniaturization of test • 2014: Start Lyme research, Launch Q fever test: Q-detect 8
Core activities Develop and perform innovative cellular diagnostics Blood testing in Biosafety Level 2 laboratory Consultancy to companies and governmental institutions 9
Innovative diagnostics Based on science From academic concepts to high volume diagnostics 10
Innovative diagnostics Aimed at scalability Individual diagnostics for large quantities 11
Innovative diagnostics Develop with stakeholders For Patients , with Patients, Healthcare professionals and Governmental Institutions 12
Diagnostic service Q fever infections Coxiella induced Interferon-gamma test (IGRA) • Supports individual diagnoses on passed Coxiella infections • Pre-vaccination screening • Supports decisions on additional diagnostics and • Supports decisions on prescription of immunosuppressive drugs 13
Contact Contact: Maarten van der Zanden maarten.vanderzanden@innatoss.com 06-37353787 Address: Molenstraat 110, 5342 CC Oss (Pivot Park, Room RE 2428) Website: www.innatoss.com 14

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Newborn Screening for SCID Anne Marie Comeau, Ph.D Deputy Director, NENSP Professor of

Newborn Screening for SCID Anne Marie Comeau, Ph.D Deputy Director, NENSP Professor of Pediatrics, UMMS NEAN/Griffin Symposium September 12, 2014 New England Newborn Screening Program Disclosure Salary-Newborn Screening NENSP- UMMS

887 views • 46 slides

TESTIMONY OF LEONARDO TRASANDE, MD, MPP ASSOCIATE PROFESSOR OF PEDIATRICS, ENVIRONMENTAL MEDICINE

TESTIMONY OF LEONARDO TRASANDE, MD, MPP ASSOCIATE PROFESSOR OF PEDIATRICS, ENVIRONMENTAL MEDICINE AND POPULATION HEALTH, NYU SCHOOL OF MEDICINE ASSOCIATE PROFESSOR OF HEALTH POLICY, NYU WAGNER SCHOOL OF PUBLIC SERVICE ASSOCIATE PROFESSOR, NYU

622 views • 6 slides

H ACKING HIV: C REATING AND A SSESSING A NOVEL CTL- BASED HIV-1 VACCINE Craig Rouskey Immunity

H ACKING HIV: C REATING AND A SSESSING A NOVEL CTL- BASED HIV-1 VACCINE Craig Rouskey Immunity Project Waag Society, Amsterdam, NL September 9, 2014 C.Rouskey | Immunity Project | Sept. 2014 I MMUNITY P ROJECT Immunity Project is a non-profit

312 views • 27 slides

PUBLIC HEALTH GRAND ROUNDS PUBLIC HEALTH GRAND ROUNDS January 21, 2010 January 21, 2010 1

PUBLIC HEALTH GRAND ROUNDS PUBLIC HEALTH GRAND ROUNDS January 21, 2010 January 21, 2010 1 PUBLIC HEALTH GRAND ROUNDS PUBLIC HEALTH GRAND ROUNDS Available on IPTV : http://intra-apps.cdc.gov/itso/iptv/iptvschedule.asp IPTV link also

1.29k views • 100 slides

PMDAs activities related to qualification of safety biomarkers for drug development Mineo

PMDAs activities related to qualification of safety biomarkers for drug development Mineo Matsumoto Office of New Drug Pharmaceuticals and Medical Devices Agency Disclaimer The views and opinions expressed in the following PowerPoint

412 views • 30 slides

Huntingtons Disease An Overview HD Center of Excellence Huntingtons Disease g Prevalence:

Huntingtons Disease An Overview HD Center of Excellence Huntingtons Disease g Prevalence: 7 per 100,000 g Age of Onset: 2 - 82 y.; mean = 39; 10% onset < 20 y.; 25% onset > 50 y. g Duration of Illness: 3 - 50 y.; mean = 18 HD

399 views • 16 slides

Motor Neurone Disease Motor Neurone Disease Hilary Fairfield Regional Care Development Adviser

Motor Neurone Disease Motor Neurone Disease Hilary Fairfield Regional Care Development Adviser Motor Neurone Disease Refers to a group of neurological diseases that selectively affect motor neurones Amyotrophic Lateral Sclerosis

271 views • 24 slides

CSF assays to detect patients with seeding- competent aggregates of Abeta, tau and alpha-

CSF assays to detect patients with seeding- competent aggregates of Abeta, tau and alpha- synuclein Claudio Soto, PhD Mitchell Center for Alzheimers disease and Related Brain Disorders, Dept of Neurology McGovern Medical School, University

485 views • 46 slides

C F L T R I C L U B G O A L The goal of the triathlon club is to encourage good health and

2 0 1 6 - 1 0 T H A N N U A L K I C K O F F M E E T I N G C F L T R I C L U B G O A L The goal of the triathlon club is to encourage good health and fitness, success, and create a sense of belonging. Members encourage one another,

116 views • 9 slides

Environmental modifiers: Prospects for rehabilitation in Huntingtons disease Jan Frich Oslo

Environmental modifiers: Prospects for rehabilitation in Huntingtons disease Jan Frich Oslo University Hospital / University of Oslo EHDN 8th Plenary Meeting, Sept 19, 2014 Background Growing interest in studying effects of exercise and

616 views • 26 slides

A GLOBAL LEADER IN EPIGENETICS I N V E S T O R P R E S E N TAT I O N M A D X : O R Y N e w Yo

A GLOBAL LEADER IN EPIGENETICS I N V E S T O R P R E S E N TAT I O N M A D X : O R Y N e w Yo r k C i t y F e b r u a r y 2 0 1 6 L E G A L N O T I C E DISCLAMER This document has been prepared by Oryzon Genomics, S.A. exclusively for

574 views • 32 slides

Neurofibromatosis Network Advocacy Program NF Network Advocacy Program Structure your

Neurofibromatosis Network Advocacy Program NF Network Advocacy Program Structure your Congressional meeting Structure Your Congressional Meeting Introduction & Thank you Explain NF Impact Personal Story Military

439 views • 14 slides

Antipsychotic Use in the Elderly: Time to Change Established Practice James Sims DNP APRN ANP-BC

9/16/2015 Antipsychotic Use in the Elderly: Time to Change Established Practice James Sims DNP APRN ANP-BC NP-C I have no conflicts of interest related to the development of this program to report. Historically Antipsychotic medications

421 views • 8 slides

Prevention and Huntington, WV Early Intervention How did we get to this? Key community

The City of Solutions Prevention and Huntington, WV Early Intervention How did we get to this? Key community collaboration and identifying leaders Data collection to know and understand the gaps What resources are currently available

1.22k views • 103 slides

CONSENT CALENDAR June 13, 2006 L I N D A M A I O Councilmember District 1 TO : Honorable Mayor

CONSENT CALENDAR June 13, 2006 L I N D A M A I O Councilmember District 1 TO : Honorable Mayor and Members of the City Council FROM : Councilmembers Linda Maio and Max Anderson SUBJECT : A Brief Presentation to Council on the Off-Label Use of

247 views • 3 slides

Drugs in Workplace Problem? 70% of estimated users of illegal drugs are employed Marijuana,

Drugs in Workplace Problem? 70% of estimated users of illegal drugs are employed Marijuana, cocaine, prescription drug 24% of workers report drinking at least once during work day in past year Cause 35% of injuries 38% to 50% of

388 views • 34 slides

HD journal presentation Godinho et al, Delivering a disease- modifying treatment for

Background for HD journal presentation Godinho et al, Delivering a disease- modifying treatment for Huntingtons disease, Drug Discovery Today , 2014 Abstract The human HTT gene and protein RNA interference (RNAi): short hairpin (SH) RNAs or

554 views • 14 slides

THE EVOLUTION OF THE FITNESS INDUSTRY PRESENTED BY BILL MCBRIDE BILL MCBRIDE PRESIDENT + CEO

THE EVOLUTION OF THE FITNESS INDUSTRY PRESENTED BY BILL MCBRIDE BILL MCBRIDE PRESIDENT + CEO Bill is a health club industry veteran leading and managing all aspects of our medical fitness centers, commercial health clubs, community centers

979 views • 48 slides

Genomic Sequencing Technologies: Challenge of incidental research findings Gail E. Henderson, PhD

Genomic Sequencing Technologies: Challenge of incidental research findings Gail E. Henderson, PhD Director, Center for Genomics and Society Department of Social Medicine UNC School of Medicine Genetics basically focused on looking at a few

151 views • 13 slides

Wel elco come me to the he Qa Qatar ar Medica ical l Exp xplor lorer er Cl Closin

Wel elco come me to the he Qa Qatar ar Medica ical l Exp xplor lorer er Cl Closin sing g Ev Event nt July y 19, , 2012 Qatar Medical Explorer Program Closing Event Welcome Note Christopher Triggle, PhD Assistant Dean for

2.24k views • 32 slides

Materials for Nucleic Acids Marcia Holden, Ross Haynes, Margaret Kline, John Butler National

NIST Standard Reference Materials for Nucleic Acids Marcia Holden, Ross Haynes, Margaret Kline, John Butler National Institute of Standards and Technology Applied Genetics Group Gaithersburg, Maryland, USA SoGAT Blood Virology meeting Vilnius,

468 views • 24 slides

Towards improved cognitive health: role of metabolomic guidance Garth J S Cooper Centre for

Towards improved cognitive health: role of metabolomic guidance Garth J S Cooper Centre for Advanced Discovery & Experimental Therapeutics (CADET) University of Manchester 13-14 April 2016 Host Institution Approach Metabolites

554 views • 13 slides

Responding to the age-old question: Why do I have

Responding to the age-old question: Why do I have to take orgo? Melissa Kosinski-Collins Associate Professor of Biology and Educa:on

358 views • 24 slides

The experts of hyaluronic acid A privately owned biotechnology company specialized in

The experts of hyaluronic acid A privately owned biotechnology company specialized in hyaluronic acid since 1992 Driven by Research Innovation Manufacturing Customer satisfaction Four main Business

231 views • 11 slides